4.8 Article

Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders

Journal

SCIENCE ADVANCES
Volume 5, Issue 2, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aau9425

Keywords

-

Funding

  1. INSERM
  2. Universite Pierre et Marie Curie [UPMC-Paris6]
  3. Agence Nationale de la Recherche (ANR EPIFEGRO 2010)
  4. People Programme Marie Curie Actions (MCA) of the European Union [290123]
  5. Societe Francaise d'Endocrinologie et Diabetologie Pediatrique through a Lilly grant
  6. Novo Nordisk Growth Hormone, Growth and Metabolism grant

Ask authors/readers for more resources

Imprinting disorders (IDs) often affect growth in humans, leading to diseases with overlapping features, regardless of the genomic region affected. IDs related to hypomethylation of the human 14q32.2 region and its DLK1/ MEG3 domain are associated with Temple syndrome (TS14). TS14 is a rare type of growth retardation, the clinical signs of which overlap considerably with those of Silver-Russell syndrome (SRS), another ID related to IGF2 downregulation at 11p15.5 region. We show that 14q32.2 hypomethylation affects expression, not only for genes at this locus but also for other imprinted genes, and especially lowers IGF2 levels at 11p15.5. Furthermore, expression of nonimprinted genes is also affected, some of which are also deregulated in SRS patients. These findings highlight the epigenetic regulation of gene expression at the DLK1/MEG3 domain. Expression profiling of TS14 and SRS patients highlights common signatures, which may account for the clinical overlap observed between TS14 and SRS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available